News for Synairgen plc (SNG.L)

Published at

Oct 11, 2023 12:22 PM

by marketscreener.com

mixed

mixed

Synairgen names Phytome's Joseph Colliver as CFO

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Appoints Joseph Colliver as chief financial officer with...

WPPN.MX WPPGF WPP.L WPP W1PP34.SA SYGGF SNG.L

Read more →
Published at

Sep 21, 2023 8:19 AM

by marketscreener.com

positive

positive

Synairgen : Interim Results -September 21, 2023 at 02:19 am EDT

Synairgen plc Interim results for the six months ended 30 June 2023 Southampton, UK - 21 September 2023: Synairgen...

SYGGF SNG.L

Read more →
Published at

Dec 23, 2022 6:06 PM

by marketscreener.com

mixed

mixed

TRADING UPDATES: SulNOx raises funds; Synairgen shares trial results

The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: ---------- SulNOx Group PLC - London-based green technology company -... | December 23, 2022

SEEN.L CBP.L SYGGF SNG.L WEN.L

Read more →
Published at

Dec 1, 2022 8:24 AM

by marketscreener.com

mixed

mixed

Synairgen : Board Changes

Synairgen plc Board Changes Southampton, UK- 1 December 2022: Synairgen plc , the respiratory... | December 1, 2022

SYGGF SNG.L FCAP.L TALK.L PETS.L CTEC.L CNVVY CNVVF

Read more →
Published at

Oct 18, 2022 8:38 AM

by etfdailynews.com

positive

positive

Synairgen (LON:SNG) Stock Price Crosses Below 200 Day Moving Average of $24.89

Read Synairgen (LON:SNG) Stock Price Crosses Below 200 Day Moving Average of $24.89 at ETF Daily News

SYGGF SNG.L

Read more →
Published at

Oct 8, 2022 9:44 AM

by etfdailynews.com

positive

positive

Synairgen (LON:SNG) Stock Price Passes Below Two Hundred Day Moving Average of $25.06

Read Synairgen (LON:SNG) Stock Price Passes Below Two Hundred Day Moving Average of $25.06 at ETF Daily News

SYGGF SNG.L

Read more →
Published at

Sep 30, 2022 8:54 AM

by etfdailynews.com

positive

positive

Synairgen (LON:SNG) Share Price Passes Below Two Hundred Day Moving Average of $25.42

Read Synairgen (LON:SNG) Share Price Passes Below Two Hundred Day Moving Average of $25.42 at ETF Daily News

SYGGF SNG.L

Read more →
Published at

Sep 28, 2022 7:46 PM

by marketscreener.com

neutral

neutral

Synairgen : Presentation at Disease Prevention and Control Summit, 7 September 2022, no audio

Don't be resistant to going antiviral: Could a broad spectrum inhaled antiviral reduce the incidence of secondary bacterial chest infections? ... | September 28, 2022

SYGGF SNG.L

Read more →
Published at

Sep 20, 2022 1:02 PM

by marketscreener.com

positive

positive

Synairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022

Analysis of 60 and 90-day data from Phase 3 SPRINTER trial in hospitalised COVID-19 patients showed that SNG001 reduced risk of recognised Long COVID symptoms Company to present full analysis of... | September 20, 2022

SYGGF SNG.L

Read more →
Published at

Aug 27, 2022 9:00 AM

by etfdailynews.com

positive

positive

Synairgen (LON:SNG) Stock Price Crosses Below Two Hundred Day Moving Average of $34.78

Read Synairgen (LON:SNG) Stock Price Crosses Below Two Hundred Day Moving Average of $34.78 at ETF Daily News

SYGGF SNG.L

Read more →
Published at

May 27, 2022 6:20 PM

by globenewswire.com

mixed

mixed

Final Results

Octopus AIM VCT plc Final Results Octopus AIM VCT plc today announces the final results for the year ended 28 February 2022. Octopus AIM VCT plc...

VTU.L VLS.L VEC.L TWD.L TIDE.L SYGGF SOS.L SNG.L RTNXF RNLX RENX.L RENE.L PCIP.L OSEC.L OOA.L MXCT.L MXCL.L MRIT.L MED.L MEAL.L LTG.L JDG.L IXI.L IUG.L ITS.L EVG.L ERGO.L EKF.L EKDHF DODS.L DNL.L CREO.L CLIN.L CLIGF CALL.L BRK.L AMS.L ACC.L 0HP1.L VRCI.L 0LD8.L

Read more →
Published at

Dec 17, 2021 9:00 AM

by globenewswire.com

mixed

mixed

Full Year Results and Notice of AGM

Hargreave Hale AIM VCT plc(the ‘Company’)(LEI: 213800LRYA19A69SIT31) FULL YEAR RESULTS AND NOTICE OF AGM Hargreave Hale AIM VCT plc announces its...

ZOO.L ZDGGF WOSGF WOSG.L WKPPF WKP.L WHTPF VTU.L VTMTF VRCI.L TSTL.L TRAK.L TPFG.L STEM.L SPXSY SPXSF SPX.L SMWH.L SFOR.L SCPPF SCE.L RNUGF RENE.L RDT.L QXT.L POLX.L PLLWF PCIP.L OTB.L OSI.L OOBHF NCCGF NCC.L MYX.L MXCT.L MXCL.L MMDDF MIRI.L MAXC LTTHF LTG.L LIO.L KRM.L KBT.L JDSPY JDDSF JD.L ITS.L IPZYF IPO.L ILIKF IKA.L IGP.L IDOX.L IDEA.L HWDN.L HWDJY HWDJF HLMAF HLMA.L HLFGY HHV.L HFG.L HALMY GFIZF GFIN.L FRGAP FBDTF ETX.L ESC.L EQLS.L EMAN.L DPP.L DNL.L CLLLF CALL.L BYPLF BYIT.L BYI.JO BOY.L BLV.L BIRD.L BDCYY BBRDF AREC.L YGEN.L VLS.L ULS.L TRI.L TIDE.L SYGGF SNG.L SHB.L RTOXF OXFCF MED.L IUG.L INS.L HDD.L FTBGF FSJ.L FPHAF FAB.L EYE.L DATA.L CNIC.L CHRT.L CCS.L BIDS.L AQX.L ANPCY ANPCF AGL.L SIS.L EKF.L EKDHF EDEN.L DXRX.L DIUXF CRWRF CRW.L C4XD.L ANCR.L ABCZF ABCM ABC.L

Read more →
Published at

Oct 9, 2021 10:06 AM

by economictimes.indiatimes.com

mixed

mixed

These are the stocks to watch as Covid enters its next phase

The first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the next stage of the pandemic means a tougher landscape for stockpicking. Nineteen months into the pandemic, a successful rollout of a Covid-19 pill could quicken and broaden the worlds recovery, opening up a plethora of investment opportunities in stock markets.

VLA.PA SYGGF SNG.L REGN34.SA REGN.MX REGN RDHL PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVAX.MX NVAX MRNA.MX MRNA M1RN34.SA INRLF GSK.L GSK GS7.DE GLAXF GIS.DE GILDD.BA GILD.MX GILD 0R2M.L 0OB3.L 0A45.L 0A3S.L ROGN.MX ROG.SW RO.SW RHHVF RHHBY RHHBF OSUR ERRFY ERFSF ERFNV.PA ERF.PA AVIR ABTCL.SN ABT.SN ABT 253840.KQ 0TDF.L 0QQ6.L MSCL.SN

Read more →
Published at

Aug 18, 2021 6:53 PM

by globenewswire.com

mixed

mixed

Portfolio Update

Octopus AIM VCT 2 plc 18 August 2021 Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc (the "Company") as at 18 August 2021 is as...

WANSF WAND.L VTU.L VTMTF VRE.L VRCI.L VEGPF VEC.L TWDLF TWD.L TAST.L SYGGF SOS.L SNG.L SDIIF SDI.L RWS.L RST.L RNUGF RENE.L QXT.L PXAMF POLX.L PLLWF PHYOF PCIP.L OSEC.L OOA.L NXFNF NFC.L NET.L MXCT.L MXCL.L MTPH.L MTP MSYS.L MER.L MED.L MEAL.L MAXC LUPGF LTTHF LTG.L LSAI.L LOOP.L LLAI.L JDG.L IXI.L IUG.L ITS.L ILIKF IKA.L IDOX.L GHH.L GBGPF GBG.L GAMCF GAMA.L G4M.L FLX.L FAB.L EVG.L ERGO.L EKF.L DXRX.L DNL.L DIUXF CRWRF CRW.L COG.L CLLLF CLIN.L CLIGF CALL.L BRK.L BREE.L ANCR.L AMS.L ADT.L 2EM.DE VEL.L TPG.L TIDE.L SPA.L RDT.L OSI.L NTQ.L MTW.L MNO.L KRM.L HDGHF HAYD.L GDR.L FDBK.L ESC.L DPP.L ACC.L ABDX.L

Read more →
Published at

Jan 13, 2021 1:00 PM

by thestreet.com

positive

positive

Synairgen Announces Commencement Of Dosing In Its International Phase III Study Of Inhaled Interferon Beta In Hospitalised COVID-19 Patients

Press release Synairgen plc ('Synairgen' or the 'Company') Synairgen announces commencement of dosing in its international Phase III study of inhaled

SYGGF SNG.L OMY.SG OMY.F

Read more →